Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Affiliation country
Publication year range
3.
Ann Surg Oncol ; 7(3): 193-8, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10791849

ABSTRACT

BACKGROUND: Thymidylate synthase (TS) is regarded as a parameter of 5-fluorouracil (5-FU) chemosensitivity for colorectal carcinoma. Recent researchers indicate that the chemosensitivity of 5-FU for colorectal carcinoma with low expression of TS is better than tumors with high expression of TS. But the relation between TS expression and overall survival of curatively resected colorectal cancer patients has been less studied. METHODS: Specimens of curatively resected colon carcinoma from 148 patients were included in this study. TS expression in the tumor was assessed by immunohistochemical staining technique, and the patients were categorized into TS-(+) and TS-(-) groups. First, the relation between TS expression and survival of patients was examined. Next, for each group, we compared survival between the chemotherapy-(+) and the chemotherapy-(-) subgroup. RESULTS: Overall survival was significantly better in the TS-(-) group (n = 107) than in the TS-(+) group (n = 41) (P = .0003). In the TS-(-) group, there was little difference between the chemotherapy-(+) and the chemotherapy-(-) subgroup. In the TS-(+) group, the survival of the chemotherapy-(+) subgroup was significantly better than the chemotherapy-(-) subgroup (P = .0439). CONCLUSIONS: TS, itself, may be a prognostic factor for colon carcinoma; and 5-FU adjuvant chemotherapy may be appropriate for colon carcinoma with high expression of TS.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Carcinoma/drug therapy , Carcinoma/enzymology , Colonic Neoplasms/drug therapy , Colonic Neoplasms/enzymology , Fluorouracil/therapeutic use , Immunohistochemistry/methods , Thymidylate Synthase/metabolism , Carcinoma/surgery , Chi-Square Distribution , Colonic Neoplasms/surgery , Female , Humans , Male , Middle Aged , Proportional Hazards Models , Statistics, Nonparametric , Survival Analysis , Treatment Outcome
4.
Jpn J Clin Oncol ; 29(11): 582-6, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10678563

ABSTRACT

A 68-year-old woman was admitted because of a rectal carcinoma with huge paraaortic lymph node metastases. Low anterior resection with regional lymph node dissection was performed, leaving the paraaortic mass. After the operation, cisplatin-5-fluorouracil therapy was used as supplemental chemotherapy. The metastatic lymph nodes shrank remarkably in response to anticancer drugs. We evaluated the effect of chemotherapy as a partial response. The physical condition of the patient was well controlled for more than 4 years until she was admitted again because of cardiac failure accompanied by relapse of abdominal lymph node swelling. She died of cardiac failure 5 years and 3 days after the operation.


Subject(s)
Adenocarcinoma/drug therapy , Adenocarcinoma/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymph Nodes/pathology , Rectal Neoplasms/drug therapy , Rectal Neoplasms/pathology , Adenocarcinoma/surgery , Aged , Aorta , Cisplatin/administration & dosage , Female , Fluorouracil/administration & dosage , Humans , Lymph Node Excision , Lymphatic Metastasis , Rectal Neoplasms/surgery , Survivors
SELECTION OF CITATIONS
SEARCH DETAIL